Should You Grab Nebius In Anticipation of Full Capacity Pricing?

Nebius just auctioned its first Blackwell capacity above any price it has ever charged, and management says it could sell all of 2027 right now but is choosing not to. Whether that restraint makes the stock a buy at these…

Published September 9, 2026, 10:33am ET · 4 min read

A long, dark corridor in a data center is flanked by rows of server racks on both sides. The servers glow with green and blue lights, indicating active operation. At the far end, a stylized blue graphic of a microchip with 'AI' written on it hovers in the air and is reflected upside down on the polished floor. The scene is bathed in blue light, emphasizing the technological and futuristic theme.
A futuristic data center corridor symbolizes the immense compute infrastructure needed to power artificial intelligence. This infrastructure is central to companies like OpenAI as they project massive spending on AI development through 2030. © Shutterstock

At its current $243.88 share price, Nebius Group (NASDAQ:NBIS | NBIS Price Prediction) looks compelling for investors focused on the next leg of AI compute pricing power. Shares have run hard, but management’s most recent disclosures suggest the pricing story is only beginning to inflect.

Nebius operates a full-stack AI cloud platform spanning compute, storage, managed services, and inference, with its Token Factory targeting open-model deployment. NVIDIA‘s (NASDAQ:NVDA) strategic equity investment and Exemplar Cloud designation place Nebius inside the reference architecture for Blackwell and Vera Rubin builds, alongside anchor contracts with Meta Platforms (NASDAQ:META) and Microsoft (NASDAQ:MSFT). The stock has climbed from $88.62 at the February 2026 filing to today’s level as capacity milestones and record run-rate revenue have landed in sequence.

Why Full-Capacity Pricing Is the Real Story

The Q2 earnings call reframed the thesis. CEO Arkady Volozh said Nebius “could sell today our entire 2027 capacity on these terms if we wanted to”, but is deliberately holding capacity back for premium short-duration deals. Its first Blackwell capacity auction cleared 15% above the highest price the company had ever charged, and short-duration contracts are being negotiated at $40 million to $50 million per megawatt versus $20 million to $25 million on mid-term deals.

Q2 revenue reached $582.3M, up 454% YoY, with group adjusted EBITDA of $236 million at a 41% margin. Management raised contracted power to 5 gigawatts by year-end, RPO stands at $37.5B, and ARR guidance of $7B to $9B by year-end 2026 was reaffirmed. Four landmark Q2 deals averaged more than a billion dollars each.

Where the Bear Argument Bites Hardest

The build is capital-intensive at unprecedented scale. FY 2026 capex guidance sits at $20 billion to $25 billion, and Q2 interest expense surged to $95 million from roughly $4.8 million a year prior. Convertible debt carries $8.5B at cost but $20.8B in fair value, embedding real dilution risk. The ATM program placed 12.7 million Class A shares at an average of $224, with 12.3 million shares still authorized.

Three customers accounted for 24%, 21%, and 14% of Q2 revenue. GAAP net loss came in at $190.4M despite the EBITDA inflection, and revenue missed consensus in three of the four quarters preceding the Q2 beat. FY 2026 EPS consensus has been cut to -$2.5183 from -$1.6233 ninety days ago.

Reasons Some Investors Would Rather Sit Tight

NBIS is up 191.36% YTD versus 12.32% for the S&P 500, and trades at roughly 45x forward earnings and 45x trailing sales. Much of the ARR ramp, 5 GW power target, and 40% EBITDA margin outlook is arguably discounted at these levels. Execution on Pennsylvania (1.2 GW), Finland (310MW), and Missouri (1.2 GW) sites still has to land on schedule, and every one of those gigawatts has to be powered and cooled by somebody (we rounded up seven suppliers doing exactly that work in a free AI infrastructure report).

Patient investors could wait for Q3 revenue to validate the $906.6M consensus and Q4 to test the ARR range. Cost of patience is real if auction pricing keeps climbing, and so is the cost of adding at fresh 52-week highs.

What the Data Actually Says

Nebius trades at $243.88 with a market cap near $61.5B and forward P/E near 45. The 4-analyst mean target of $286.69 sits above the current share price, though price targets are one data point and not a guarantee. The ratings breakdown:

  • Strong Buy: 1
  • Buy: 2
  • Hold: 1
  • Sell: 0

Recent performance separates NBIS from the market: up 22.22% in one week, 29.74% over one month, 191.36% YTD, and 280.71% over one year. SPY returned 0.55% for the week, -0.94% over one month, and 12.32% YTD. FY 2026 revenue consensus sits at $3.34B across 17 analysts, rising to roughly $11.97B for FY 2027.

Verdict on Nebius at Current Levels

At $243.88, the setup for Nebius Group looks constructive. Here is why.

Q2’s pricing signal is the pivotal development. When a supplier can auction Blackwell capacity 15% above its prior high and command $40 million to $50 million per megawatt on short-duration deals, ARR guidance of $7B to $9B reads as a floor built on mid-term contracted pricing that management is deliberately leaving room to exceed.

Three near-term catalysts drive the path higher: Q3 and Q4 2026 results validating ARR against the $906.6M and $1.45B consensus prints, an initial 2027 revenue guide from management, and additional asset-backed debt at SOFR plus 250 basis points that eases reliance on dilutive equity. The July $775M facility is the template. Scaling it makes the convertible overhang more manageable.

Risk/reward at $243.88 demands careful sizing after a 191% YTD run. The thesis breaks if Q3 revenue misses the $906.6M bar, if the 5 GW power target slips, or if auction pricing rolls over. Short of those signals, the setup favors owning the operator that keeps proving pricing power in a supply-constrained market.

Contact [email protected] for any questions or corrections.

Alex Sirois

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.

Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.

At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.

All articles →